MDGL · Madrigal Pharmaceuticals, Inc.
$507.56
+0.19 (+0.04%)
At close · Aug 14
Market Cap
$11.73B
Shares
23.10M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$300,000,000
as of 2024-05-31
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-05 | — | $300,000,000 | $300,000,000 as of 2026-03-31 | — | 10-Q , filed 2026-05-06 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2012-12-31 | $32,000 | 10-K, filed 2015-03-12 |
Key facts
CIK
1157601
CUSIP
558868105
13F (30d)
385 filings
382 filers
Visit website
Investor relations